Patents by Inventor Hana KAMMOUN

Hana KAMMOUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant strains
    Patent number: 9528086
    Abstract: A genetically attenuated Bordetella pertussis strain includes a mutated pertussis toxin (ptx) gene, and a heterologous ampG gene, and a hybrid protein including the N-terminal fragment of filamentous haemagglutinin (FHA) and a heterologous epitope or antigenic protein or protein fragment, different from FHA. The strain can be used in an attenuated vaccine for the treatment or prophylaxis of an infectious disease.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: December 27, 2016
    Assignees: UNIVERSITÉ DROIT ET SANTÉ LILLE II, INSERM, INSTITUT PASTEUR DE LILLE
    Inventors: Camille Locht, Nathalie Mielcarek, Hana Kammoun
  • Novel Recombinant Bordetella Strains
    Publication number: 20150210978
    Abstract: A genetically attenuated Bordetella pertussis strain includes a mutated pertussis toxin (ptx) gene, and a heterologous ampG gene, and a hybrid protein including the N-terminal fragment of filamentous haemagglutinin (FHA) and a heterologous epitope or antigenic protein or protein fragment, different from FHA. The strain can be used in an attenuated vaccine for the treatment or prophylaxis of an infectious disease.
    Type: Application
    Filed: April 9, 2015
    Publication date: July 30, 2015
    Inventors: Camille LOCHT, Nathalie MIELCAREK, Hana KAMMOUN